Evidence map›Paper›PMID 35346287›Full record

ArticleOrphanet journal of rare diseases2022

Genotype-phenotype correlation and natural history analyses in a Chinese cohort with pelizaeus-merzbacher disease.

Ruoyu Duan, Haoran Ji, Huifang Yan, Junyu Wang, Yu Zhang, Qian Zhang, Dongxiao Li, Binbin Cao, Qiang Gu, Ye Wu and 3 more

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Ruoyu DuanDepartment of Pediatrics, Peking University First Hospital, Beijing, 100034, China.
Haoran JiDepartment of Pediatrics, Peking University First Hospital, Beijing, 100034, China.
Huifang YanDepartment of Pediatrics, Peking University First Hospital, Beijing, 100034, China.
Junyu WangDepartment of Pediatrics, Peking University First Hospital, Beijing, 100034, China.
Yu ZhangDepartment of Pediatrics, Peking University First Hospital, Beijing, 100034, China.
Qian ZhangDepartment of Children's Development and Rehabilitation, Peking University First Hospital, Beijing, 100034, China.
Dongxiao LiDepartment of Pediatrics, Peking University First Hospital, Beijing, 100034, China.
Binbin CaoDepartment of Pediatrics, Peking University First Hospital, Beijing, 100034, China.
Qiang GuDepartment of Pediatrics, Peking University First Hospital, Beijing, 100034, China.
Ye WuDepartment of Pediatrics, Peking University First Hospital, Beijing, 100034, China.
Yuwu JiangDepartment of Pediatrics, Peking University First Hospital, Beijing, 100034, China.
Ming LiDepartment of Pediatrics, Peking University First Hospital, Beijing, 100034, China. drliming@163.com.
Jingmin WangDepartment of Pediatrics, Peking University First Hospital, Beijing, 100034, China. wang66jm@163.com.ORCID 0000-0001-5263-1013
Peking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe natural history and genotype-phenotype correlation of Pelizaeus-Merzbacher disease (PMD) of Chinese patients has been rarely reported.

methodPatients who met the criteria for PMD were enrolled in our study. Genomic analysis was conducted by multiplex ligation probe amplification (MLPA) and Sanger or whole-exome sequencing (WES). Natural history differences and genotype-phenotype correlations were analyzed.

resultA total of 111 patients were enrolled in our follow-up study. The median follow-up interval was 53 m (1185). Among PMD patients, developmental delay was the most common sign, and nystagmus and hypotonia were the most common initial symptoms observed. A total of 78.4% of the patients were able to control their head, and 72.1% could speak words. However, few of the patients could stand (9.0%) or walk (4.5%) by themselves. Nystagmus improved in more than half of the patients, and hypotonia sometimes deteriorated to movement disorders. More PLP1 point mutations patients were categorized into severe group, while more patients with PLP1 duplications were categorized into mild group (p < 0.001). Compared to patients in mild groups, those in the severe group had earlier disease onset and had acquired fewer skills at a later age.

conclusionPMD patients have early disease onset with nystagmus and hypotonia followed by decreased nystagmus and movement disorders, such as spasticit. Patients with PLP1 duplication were more likely to be categorized into the mild group, whereas patients with point mutations were more likely to be categorized into the severe group.

Indexed as

Pelizaeus-Merzbacher DiseaseChinaFollow-Up StudiesGenetic Association StudiesHumansMyelin Proteolipid ProteinMyelin Proteolipid ProteinChinese cohortGenotypeNatural historyPelizaeus–merzbacher diseasePhenotype

Identifiers

PMID35346287
PMCPMC8962489
OpenAlexW4220689224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.